Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Aspen Pharmacare Holdings Ltd

APN.J ✓ COMPLIANT ☆ Track — members

JSE · Healthcare · Pharmaceuticals ·

South Africa Mid Cap Analyst: HOLD

Last Close

$9.18

▼ -0.40%

Market Cap $4.10B · Vol 866.61K

Key Metrics

P/E Ratio

N/A

FWD: 12.26

Market Cap

$4.10B

Mid Cap

Div Yield

1.43%

Annual dividend

EPS Growth

-11.20%

YoY

RSI (14)

50.63

Momentum

Beta

0.31

vs Market

52W High

$10.04

7.25% below

52W Low

$5.66

75.35% above

Volume

866.61K

Avg 1.32M

P/B

0.62

Price-to-book

ROE

5.52%

Return on equity

Free Float

59.94%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Aspen Pharmacare Holdings Ltd (APN.J) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does APN.J pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.59%

+0.71%

+8.52%

+13.21%

YTD

+25.90%

+41.32%

-8.48%

-21.85%

Financials & Valuation

TTM · Annual

Total Revenue	$2.44B
Net Income	$-61,031,276.00
Revenue Growth (YoY)	-4.32%
Gross Margin	44.11%
Operating Margin	17.30%
Net Profit Margin	-2.50%
ROE	5.52%
ROA · ROIC	-0.09% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	12.26
PEG Ratio	N/A
P/S	1.22
P/B	0.62
P/FCF	510.13
EPS Growth	-11.20%
Outstanding Shares	446.25M

Technical Indicators

50-Day SMA	$9.33
200-Day SMA	$8.02
RSI (14)	50.63
Beta	0.31
52-Week High	$10.04
52-Week Low	$5.66

Volume Today	866.61K
Avg Daily Volume (30D)	1.32M
Relative Volume	0.65x
Volatility (10D)	26.15
Volatility (30D)	34.41
Free Float	59.94%

Analyst Consensus

HOLD

Current Price $9.18

Mean Target $9.53

52W Low$5.66 52W High$10.04

Current

Target

$5.66 $10.04

Current Analyst target

+3.84% upside potential · 5 analysts

Identifiers

ExchangeJSE

FIGIBBG001SC9GB3

ISINZAE000066692

CountrySouth Africa

Sub-IndustryGeneric Pharmaceuticals

Earnings DateSep 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd +0.40% 4578.T Otsuka Holdings Co Ltd +0.12% CIPLA.NS Cipla Ltd +0.40% ZYDUSLIFE.NS Zydus Lifesciences Ltd -1.45% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +3.49%

Company Profile

Aspen Pharmacare Holdings Limited is a South Africa-based global specialty and branded multinational pharmaceutical company. The Company focuses on marketing and manufacturing a range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. Its segments include Prescription, Over the counter (OTC), Injectables, Active Pharmaceutical Ingredients (API), Finished Dose Form (FDF) and Heparin. It offers sterile products in injectable form primarily administered in hospitals and also those prescribed and administered by either physicians or in a retail pharmacy environment. Its key brands include Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon and Xylocaine (Injectables). Its OTC segment includes products that do not require prescriptions and are primarily sold in the retail pharmacy and fast-moving consumer goods sectors. Its Prescription segment includes products which generally require a prescription from a healthcare professional.